REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. for securities fraud, covering purchases made between November 2, 2023, and October 30, 2024.
January 20, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosen Law Firm has initiated a class action lawsuit against Regeneron Pharmaceuticals, Inc. for alleged securities fraud, affecting investors who purchased shares between November 2, 2023, and October 30, 2024.
The filing of a class action lawsuit for securities fraud is likely to negatively impact Regeneron's stock price in the short term as it raises concerns about the company's financial practices and potential liabilities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100